BACTERIOLOGICAL EVALUATION OF CEFACLOR, A NEW ORAL CEPHALOSPORIN ANTIBIOTIC

DOI Web Site

Bibliographic Information

Other Title
  • 新しい経口用セファロスポリン系抗生物質Cefaclorに関する細菌学的評価
  • アタラシイ ケイコウヨウ セファロスポリンケイ コウセイ ブッシツ Cefac

Search this article

Abstract

The in vitro and in vivo antibacterial activity of cefaclor (CCL), a new oral cephalosporin antibiotic, was compared with that of cephalexin (CEX). The following results were obtained.<BR>1) CCL showed broad antibacterial spectrum against gram-positive and gram-negative bacteria. The antibacterial activity of CCL was 2 to 8 times superior to that of CEX.<BR>2) Sensitivity distribution of clinical isolates to CCL exhibited 2 to 8 times stronger activity than CEX against S. aureus, E. coli, K. pneumoniae and P. mirabilis.<BR>3) Influence of medium pH and inoculum size on in vitro antibacterial activity of CCL showed the same tendency to CEX. The antibacterial activity of CCL was slightly influenced by the addition of horse serum.<BR>4) The effect of CCL on growth curve of S. aureus, E. coli and K. pneumoniae was also studied. CCL had a stronger bactericidal and lytic activity against E. coli and K. pneumoniae than CEX does.<BR>5) In protective effect studies on experimental mice infected with S. aureus, S. pyogenes, S. pneumoniae, E. coli and K. pneumoniae respectively the activity (ED50) of CCL was 4 to 10 times superior to that of CEX. In E. coli and K. pneumoniae infections with large challenge dose CCL was much more effective than CEX was.

Journal

  • CHEMOTHERAPY

    CHEMOTHERAPY 27 (Supplement7), 38-58, 1979

    Japanese Society of Chemotherapy

Details 詳細情報について

Report a problem

Back to top